INSP
Inspire Medical Systems, Inc.NYSEHealthcare$54.99+2.52%ClosedMarket Cap: $1.58B
As of 2026-04-06
Valuation
P/E (TTM)
10.89
PEG
0.06
P/B
2.01
P/S
1.71
EV/EBITDA
21.72
DCF Value
$136.96
FCF Yield
5.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
85.4%
Operating Margin
5.6%
Net Margin
15.9%
ROE
21.1%
ROA
15.8%
ROIC
6.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $269.1M | 86.6% | $46.1M | $136.1M | $4.66 | — |
| FY 2025 | $912.0M | 85.4% | $51.0M | $145.4M | $4.89 | — |
| Q3 2025 | $224.5M | 85.8% | $9.6M | $9.9M | $0.34 | — |
| Q2 2025 | $217.1M | 84.0% | $-3.3M | $-3.6M | $-0.12 | — |
| Q1 2025 | $201.3M | 84.7% | $-1.5M | $3.0M | $0.10 | — |
| Q4 2024 | $239.7M | 85.0% | $31.9M | $35.2M | $1.15 | — |
| FY 2024 | $802.8M | 84.7% | $36.1M | $53.5M | $1.75 | — |
| Q3 2024 | $203.2M | 84.1% | $14.3M | $18.5M | $0.60 | — |
| Q2 2024 | $195.9M | 84.8% | $5.1M | $9.8M | $0.32 | — |
| Q1 2024 | $164.0M | 84.9% | $-15.2M | $-10.0M | $-0.34 | — |
| Q4 2023 | $192.5M | 85.4% | $9.3M | $14.8M | $0.49 | — |
| FY 2023 | $624.8M | 84.5% | $-40.3M | $-21.2M | $-0.72 | — |